Clinical Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium Infection and Cancer: Biology, Therapeutics, and Prevention
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dong, Y.
Right arrow Articles by Tokuda, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dong, Y.
Right arrow Articles by Tokuda, M.
Clinical Cancer Research Vol. 6, 4253-4258, November 2000
© 2000 American Association for Cancer Research


Regular Articles

Prognostic Significance of Cyclin E Overexpression in Laryngeal Squamous Cell Carcinomas1

Youyi Dong, Li Sui, Yuji Tai, Katsuyoshi Sugimoto, Tomohiro Hirao and Masaaki Tokuda2

Departments of Physiology [Y. D., Y. Y., K. S., M. T.], Perinato-Gynecology [L. S.], and Hygiene and Public Health [T. H.], Kagawa Medical University, Kagawa 761-0793, Japan

ABSTRACT

Cyclin E plays a pivotal role in the regulation of G1-S transition and relates to malignant transformation of cells. However, the clinical significance of cyclin E in patients with laryngeal squamous cell carcinoma (LSCC) remains unknown. We examined the expression of cyclin E in 102 patients with LSCC and analyzed its relation to clinicopathological parameters, cell proliferation, and clinical outcome. Cyclin E overexpression was observed in 54 cases (52.94%) of LSCC and was significantly correlated with the tumor site (P = 0.012), tumor size (P = 0.006), poor differentiation (P = 0.026), lymph node metastasis (P = 0.012), and advanced stage (P = 0.002). A positive correlation between the cyclin E expression and proliferative activity of tumor cells was found (r = 0.896; P < 0.0001). Kaplan-Meier analysis showed that shorter disease-free and overall survival was significantly associated with proliferating cell nuclear antigen (PCNA) overexpression and cyclin E overexpression. When PCNA and cyclin E are combined, the patients with both PCNA overexpression and cyclin E overexpression had the poorest prognoses when compared with the other cases. Additionally, in early stage (I–II) cases, cyclin E was also revealed to possess a significant prognostic role. By multivariate analysis, lymph node metastasis and cyclin E overexpression were independent prognostic factors for disease-free survival, and tumor size, lymph node metastasis, advanced stage, as well as cyclin E overexpression were independent prognostic factors for overall survival. These findings indicate that cyclin E overexpression is associated with unfavorable clinicopathological parameters and represents an independent marker for cell proliferation and prognosis of LSCC.




This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
J. Brzezinski, A. Migodzinski, A. Toczek, J. Tazbir, and M. Dedecjus
Patterns of Cyclin E, Retinoblastoma Protein, and p21Cip1/WAF1 Immunostaining in the Oncogenesis of Papillary Thyroid Carcinoma
Clin. Cancer Res., February 1, 2005; 11(3): 1037 - 1043.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
Y. Dong, L. Sui, Y. Watanabe, F. Yamaguchi, N. Hatano, and M. Tokuda
Prognostic Significance of Jab1 Expression in Laryngeal Squamous Cell Carcinomas
Clin. Cancer Res., January 1, 2005; 11(1): 259 - 266.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
M. Rodriguez-Pinilla, J. L. Rodriguez-Peralto, R. Hitt, J. J. Sanchez, C. Ballestin, A. Diez, L. Sanchez-Verde, F. Alameda, and M. Sanchez-Cespedes
Cyclin A as a Predictive Factor for Chemotherapy Response in Advanced Head and Neck Cancer
Clin. Cancer Res., December 15, 2004; 10(24): 8486 - 8492.
[Abstract] [Full Text] [PDF]


Home page
Ann OncolHome page
A. Pich, L. Chiusa, and R. Navone
Prognostic relevance of cell proliferation in head and neck tumors
Ann. Onc., September 1, 2004; 15(9): 1319 - 1329.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2000 by the American Association for Cancer Research.